Secondary Metabolites of Teucrium Species with Toxic Effects
The genus Teucrium L. has a long-term use in folk medicine, however there are some implications for human health related to the consumption of germander-containing products. Numerous cases of hepatotoxicity have been reported, mostly in Europe, where the
- PDF / 14,074,445 Bytes
- 446 Pages / 439.43 x 683.15 pts Page_size
- 91 Downloads / 190 Views
Teucrium Species: Biology and Applications
Teucrium Species: Biology and Applications
Milan Stanković Editor
Teucrium Species: Biology and Applications
Editor Milan Stanković Department of Biology and Ecology, Faculty of Science University of Kragujevac Kragujevac, Serbia
ISBN 978-3-030-52158-5 ISBN 978-3-030-52159-2 (eBook) https://doi.org/10.1007/978-3-030-52159-2 © Springer Nature Switzerland AG 2020 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Foreword
Nature is a major source of our current medicines, and many (semi)synthetic medicines have been developed from natural products. These compounds have been found by studying traditional medicines and by screening extracts from various organisms, particularly plants and microorganisms. In fact, about 25% of all western drugs are from plants. Microorganisms are particularly the source of antibiotics and antitumor medicines. In the meantime, for most ailments, good medicines are available; however, in the field of antibiotics and parasitic diseases, the resistance of microbes and parasites against available medicine is causing a major problem. New drugs are urgently needed, drugs that particularly should be available for the poor in developing countries at a reasonable price. As it concerns drugs cure a patient, the use is only for short periods. Consequently, the market is small if compared to, for example, an antihypertension drug that a patient takes every day for many years. Therefore, it is difficult to earn back the high costs for developing a new drug. The big pharma is thus not investing effort in developing such drugs, but if good leads are available, they may develop these further, as we can learn from the Nobel Prize
Data Loading...
